Werewolf Therapeutics Inc...
1.39
0.04 (2.96%)
At close: Jan 15, 2025, 1:16 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 19.94M 16.40M n/a n/a n/a
Cost of Revenue 38.91M 2.51M 735.00K 777.00K 463.00K
Gross Profit -18.96M 13.89M -735.00K -777.00K -463.00K
Operating Income -40.50M -56.06M -50.09M -22.40M -9.94M
Interest Income 7.42M 1.91M 104.00K 101.00K 372.00K
Pretax Income -37.37M -53.81M -49.98M -15.04M -10.25M
Net Income -37.37M -51.56M -49.77M -14.94M -10.99M
Selling & General & Admin 18.67M 18.70M 14.82M 5.76M 3.60M
Research & Development 41.78M 53.76M 35.27M 16.64M 6.34M
Other Expenses n/a 2.25M 104.00K 7.26M 430.00K
Operating Expenses 60.45M 72.46M 50.09M 22.40M 9.94M
Interest Expense 3.14M n/a n/a n/a 372.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 60.45M 72.46M 50.09M 22.40M 9.94M
Income Tax n/a -2.25M -216.00K -101.00K 742.00K
Shares Outstanding (Basic) 35.65M 28.86M 27.31M 28.66M 28.66M
Shares Outstanding (Diluted) 35.65M 28.86M 27.31M 28.66M 28.66M
EPS (Basic) -1.05 -1.79 -1.82 -0.52 -0.38
EPS (Diluted) -1.05 -1.79 -1.82 -0.52 -0.38
EBITDA -32.47M -51.30M -49.25M -14.26M -9.41M
Depreciation & Amortization 1.76M 2.51M 735.00K 777.00K 463.00K